Innovation in Endotoxin Testing ensuring patient safety and scientific soundness - without using Horseshoe Crabs!

Hyglos GmbH - a bioMérieux company - is a biotech company located in Biotechnology Center Bernried, Munich area, Germany. We have a strong focus on innovation in the field of Endotoxin Detection. Our sustainable assays are based on Phage Recombinant Proteins and Recombinant Horseshoe Crab Factor C (rFC), produced completely without using the blood from horseshoe crabs. 

Since 1 July 2016, our endotoxin test methods are included in Chapter 5.1.10 of the European Pharmacopoeia as approved alternative methods. Our endotoxin tests EndoLISA® and EndoZyme® II  bring important advantages to users in biopharmaceutical research and industry, overcoming limitations of the LAL test (Limulus amebocyte lysate) which still relies on lysate from the blood of the horseshoe (Limulus) crab. In 2014, Hyglos first introduced the Endo-RS® Endotoxin Recovery Method, a world-first sample preparation method for full recovery of endotoxin in samples affected by Low Endotoxin Recovery (LER), addressed by e.g. the FDA. Hyglos offers a complete service package for LER solutions, including hold-time studies and demasking protocol development.

Follow Hyglos:

EndoLISA Video User Guide: